Pomerantz LLP is investigating potential securities claims on behalf of Ambarella, Inc. investors and advises affected shareholders to contact the firm. The March 3, 2026 notice appears among a cluster of same‑day Pomerantz alerts — which include an inquiry into Novo Nordisk — indicating coordinated communications to investors across multiple companies.
Click a connection line between nodes to view confidence and evidence.